021-51111890
购物车（）
sales@molnova.cn
NBI-31772
CAS No. 374620-70-9
NBI-31772 ( NBI 31772; NBI31772 )
产品货号. M28583 CAS No. 374620-70-9
NBI-31772 is the potent inhibitor of insulin-like growth factor-1 binding protein (IGFBP, Ki = 47 nM). NBI-31772 can be used in research on IGF-responsive diseases.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥599 | 有现货 |
|
| 5MG | ￥988 | 有现货 |
|
| 10MG | ￥1596 | 有现货 |
|
| 25MG | ￥3467 | 有现货 |
|
| 50MG | ￥5176 | 有现货 |
|
| 100MG | ￥7209 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NBI-31772
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述NBI-31772 is the potent inhibitor of insulin-like growth factor-1 binding protein (IGFBP, Ki = 47 nM). NBI-31772 can be used in research on IGF-responsive diseases.
-
产品描述NBI-31772 is the potent inhibitor of insulin-like growth factor-1 binding protein (IGFBP, Ki = 47 nM). NBI-31772 can be used in research on IGF-responsive diseases.
-
同义词NBI 31772; NBI31772
-
通路Angiogenesis
-
靶点IGF-1R
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number374620-70-9
-
分子量341.3
-
分子式C17H11NO7
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOC(=O)c1cc2cc(O)c(O)cc2c(n1)C(=O)c1ccc(O)c(O)c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Issac M, et al. Mollecarbamates, Molleureas, and Molledihydroisoquinolone, o-Carboxyphenethylamide Metabolites of the Ascidian Didemnum molle Collected in Madagascar. J Nat Prod. 2017 Jun 23;80(6):1844-1852.
产品手册
关联产品
-
IGF-I 24-41
IGF-I (24-41) is a 24-41 amino acid fragment of Insulin-like Growth Factor I (IGF-I). IGF-I is partly responsible for systemic GH activities although it possesses a wide number of own properties (anabolic, antioxidant, anti-inflammatory and cytoprotective actions).
-
NBI-31772
NBI-31772 is the potent inhibitor of insulin-like growth factor-1 binding protein (IGFBP, Ki = 47 nM). NBI-31772 can be used in research on IGF-responsive diseases.
-
Cys-Gly
L-Cysteinylglycine, is a biologically important compound since it is formed during the γ-glutamyl cycle.
